Literature DB >> 8754833

Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells.

D Agrawal1, P Hauser, F McPherson, F Dong, A Garcia, W J Pledger.   

Abstract

We have investigated the regulation of p27kip1, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells during growth factor-stimulated transition from quiescence (G0) to a proliferative (G1) state. The level of p27kip1 protein falls dramatically after mitogenic stimulation and is accompanied by a decrease in cyclin E associated p27kip1, as well as a transient increase in cyclin D1-associated p27kip1 that later declines concomitantly with the loss of total p27kip1. Analysis of metabolically labelled cells revealed that cyclin D2, cyclin D3, and cdk4 were also partnered with p27kip1 in quiescent BALB/c 3T3 cells and that this association decreased after platelet-derived growth factor (PDGF) treatment. Furthermore, the decline in p27kip1 and reduced association with cyclin D3, initiated by the addition of PDGF but not plasma-derived factors, suggested that these changes are involved in competence, the first step in the exit from G0. Synthesis of p27kip1 as determined by incorporation of [35S]methionine was repressed upon mitogenic stimulation, and PDGF was sufficient to elicit this repression within 2 to 3 h. Pulse-chase experiments demonstrated the reduced rate of synthesis was not the result of an increased rate of degradation. Full repression of p27kip1 synthesis required the continued presence of PDGF and failed to occur in the presence of the RNA polymerase inhibitor 5,6-dichlorobenzimidazole riboside. These characteristics demonstrate that repression was a late effect of PDGF and was consistent with our finding that conditional expression of activated H-ras did not affect synthesis of p27kip1. Northern (RNA) analysis of p27kip1 mRNA revealed that the repression was not accompanied by a corresponding decrease in p27kip1 mRNA, suggesting that the PDGF-regulated decrease in p27kip1 expression occurred through a translational mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8754833      PMCID: PMC231431          DOI: 10.1128/MCB.16.8.4327

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

1.  An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis.

Authors:  W J Pledger; C D Stiles; H N Antoniades; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

Review 2.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

3.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.

Authors:  K F Macleod; N Sherry; G Hannon; D Beach; T Tokino; K Kinzler; B Vogelstein; T Jacks
Journal:  Genes Dev       Date:  1995-04-15       Impact factor: 11.361

4.  Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.

Authors:  Y Luo; J Hurwitz; J Massagué
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

Review 5.  Growth factors and cancer.

Authors:  S A Aaronson
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

6.  Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.

Authors:  H Hirai; M F Roussel; J Y Kato; R A Ashmun; C J Sherr
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

7.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Authors:  H Matsushime; M F Roussel; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

8.  Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family.

Authors:  A Koff; F Cross; A Fisher; J Schumacher; K Leguellec; M Philippe; J M Roberts
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

Review 9.  Mammalian antiproliferative signals and their targets.

Authors:  J Massagué; K Polyak
Journal:  Curr Opin Genet Dev       Date:  1995-02       Impact factor: 5.578

10.  The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes.

Authors:  L Zhu; G Enders; J A Lees; R L Beijersbergen; R Bernards; E Harlow
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  47 in total

1.  A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA.

Authors:  S S Millard; A Vidal; M Markus; A Koff
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line.

Authors:  Jiang Li; Xin-Ke Yang; Xin-Xin Yu; Meng-Liang Ge; Wen-Liang Wang; Jie Zhang; Yun-De Hou
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

3.  The major transcription initiation site of the p27Kip1 gene is conserved in human and mouse and produces a long 5'-UTR.

Authors:  J Coleman; M Hawkinson; R Miskimins; W K Miskimins
Journal:  BMC Mol Biol       Date:  2001-10-11       Impact factor: 2.946

4.  ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR.

Authors:  Michael Kullmann; Ulrich Göpfert; Basile Siewe; Ludger Hengst
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

5.  Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.

Authors:  Xin-Hua Zhu; Hoang Nguyen; H Dorota Halicka; Frank Traganos; Andrew Koff
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 6.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

7.  Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer.

Authors:  Guang Chen; Na Yang; Xiang Wang; Si-Yuan Zheng; Yi Chen; Lin-Jiang Tong; Yi-Xue Li; Ling-Hua Meng; Jian Ding
Journal:  J Mol Med (Berl)       Date:  2010-05-28       Impact factor: 4.599

8.  p27Kip1 inhibits the cell cycle through non-canonical G1/S phase-specific gatekeeper mechanism.

Authors:  Savitha S Sharma; Le Ma; W Jackson Pledger
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Embryonic lethal abnormal vision-like HuR-dependent mRNA stability regulates post-transcriptional expression of cyclin-dependent kinase inhibitor p27Kip1.

Authors:  Gudrun Ziegeler; Jie Ming; Jana C Koseki; Sema Sevinc; Ting Chen; Suleyman Ergun; Xuebin Qin; Bertal H Aktas
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

10.  EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression.

Authors:  Zizheng Dong; Jian-Ting Zhang
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.